Eng Seng Lim
Direktor/Vorstandsmitglied bei NEW SILKROUTES GROUP LIMITED
Profil
Eng Seng Lim is an Independent Non-Executive Director at New Silkroutes Group Ltd.
He previously served as Chairman at ViAqua Therapeutics Ltd.
in 2017, Vice President at The Royal Bank of Scotland NV (Hong Kong) from 2010 to 2012, General Manager at Fullerton Healthcare Group Pte Ltd.
from 2013 to 2015, and General Manager at Sin Capital Group Pte Ltd.
from 2012 to 2013.
Mr. Lim received his undergraduate degree from the University of Lancaster in 2003.
Aktive Positionen von Eng Seng Lim
| Unternehmen | Position | Beginn |
|---|---|---|
| NEW SILKROUTES GROUP LIMITED | Direktor/Vorstandsmitglied | 11.01.2021 |
Ehemalige bekannte Positionen von Eng Seng Lim
| Unternehmen | Position | Ende |
|---|---|---|
ViAqua Therapeutics Ltd.
 ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Vorsitzender | 01.12.2017 |
Fullerton Healthcare Group Pte Ltd.
 Fullerton Healthcare Group Pte Ltd. Packaged SoftwareTechnology Services Fullerton Healthcare Group Pte. Ltd. engages in the provision of vertically integrated healthcare platform. Its services include managed care and network management; primary care; executive health screening; and diagnostic, specialty, and ancillary care. The company was founded by Michael Tan, David Sin and Daniel Chan in 2011 and is headquartered in Singapore. | Corporate Officer/Principal | 01.01.2015 |
Sin Capital Group Pte Ltd.
 Sin Capital Group Pte Ltd. Financial ConglomeratesFinance Sin Capital Group Pte Ltd. provides investment services. The private company is based in Singapore, Singapore. | Corporate Officer/Principal | 01.01.2013 |
The Royal Bank of Scotland NV (Hong Kong)
 The Royal Bank of Scotland NV (Hong Kong) Major BanksFinance Part of NatWest Group Plc, The Royal Bank of Scotland NV (Hong Kong) is a banking services provider. The company is based in Hong Kong, Hong Kong. | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Eng Seng Lim
| University of Lancaster | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEW SILKROUTES GROUP LIMITED | Distribution Services |
| Private Unternehmen | 4 |
|---|---|
Fullerton Healthcare Group Pte Ltd.
Fullerton Healthcare Group Pte Ltd. Packaged SoftwareTechnology Services Fullerton Healthcare Group Pte. Ltd. engages in the provision of vertically integrated healthcare platform. Its services include managed care and network management; primary care; executive health screening; and diagnostic, specialty, and ancillary care. The company was founded by Michael Tan, David Sin and Daniel Chan in 2011 and is headquartered in Singapore. | Technology Services |
Sin Capital Group Pte Ltd.
Sin Capital Group Pte Ltd. Financial ConglomeratesFinance Sin Capital Group Pte Ltd. provides investment services. The private company is based in Singapore, Singapore. | Finance |
The Royal Bank of Scotland NV (Hong Kong)
The Royal Bank of Scotland NV (Hong Kong) Major BanksFinance Part of NatWest Group Plc, The Royal Bank of Scotland NV (Hong Kong) is a banking services provider. The company is based in Hong Kong, Hong Kong. | Finance |
ViAqua Therapeutics Ltd.
ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Health Technology |
